Relationship between serum albumin and pulse wave velocity in patients on continuous ambulatory peritoneal dialysis

Vascular Health and Risk Management

Volumn 4, Issue 4, 2008, Pages 871-876

  Cheng, Li Tao ^a   Tang, Li Jun ^a,b   Chen, Hui Min ^a,c   Tang, Wen ^a   Wang, Tao ^a  

^a PEKING UNIVERSITY THIRD HOSPITAL   (China)

^b SHANDONG UNIVERSITY   (China)

^c GUANGDONG PROVINCIAL HOSPITAL OF CHINESE MEDICINE   (China)

Author keywords

Arterial stiffness; Cardiovascular events; Hypoalbuminemia; Peritoneal dialysis; Pulse wave velocity

Indexed keywords

ALBUMIN; ANTIHYPERTENSIVE AGENT; C REACTIVE PROTEIN; CHOLESTEROL;

ADULT; AGE; AGED; ALBUMIN BLOOD LEVEL; ARTERIAL STIFFNESS; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAROTID ARTERY PULSE; CHOLESTEROL BLOOD LEVEL; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; CORRELATION FUNCTION; DIABETES MELLITUS; FEMALE; FEMORAL ARTERY; HEMODIALYSIS PATIENT; HUMAN; HYPERTENSION; HYPOALBUMINEMIA; INFLAMMATION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIPLE REGRESSION; PROTEIN BLOOD LEVEL; PULSE WAVE; RISK FACTOR; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION;

AGED; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CAROTID ARTERIES; CROSS-SECTIONAL STUDIES; ELASTICITY; FEMALE; FEMORAL ARTERY; HUMANS; HYPOALBUMINEMIA; INFLAMMATION; MALE; MIDDLE AGED; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; RISK ASSESSMENT; RISK FACTORS; SERUM ALBUMIN;

EID: 52249088381     PISSN: 11766344     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Asmar R, Benetos A, Topouchian J, et al. 1995. Assessment of arterial distensibility by automatic pulse wave velocity measurement: validation and clinical application study. Hypertension, 26:485-90.
2. Asmar R, Rudnichi A, Blacher J, et al. 2001. Pulsepressure and aortic pulse wave are markers of cardiovascular risk in hypertensive populations. Am J Hypertens, 14:91-7.
3. Benetos A, Rudnichi A, Safar M, et al. 1998. Pulse pressure and cardiovascular mortality in normotensive and hypertensive subjects. Hypertension, 32:560-4.
4. Blacher J, Guerin AP, Pannier B, et al. 1999. Impact of aortic stiffness on survival in end-stage renal disease. Circulation, 99:2434-9.
5. Blann AD. 2004. Von Willebrand factor and forearm blood flow as indicators of endothelial dysfunction. Atherosclerosis, 176:423-4.
6. Borawski J, Naumnik B, Pawlak K, et al. 2001. Endothelial dysfunction marker Von Willebrand factor antigen in haemodialysis patients: associations with pre-dialysis blood pressure and the acute phase response. Nephrol Dial Transplant, 16:1442-7.
7. Boutouyrie P, Tropeano AI, Asmar R, et al. 2002. Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: a longitudinal study. Hypertension, 39:2085-90.
8. Cameron JS. 1987. The nephrotic syndrome and its complications. Am J Kidney Dis, 10:157-71.
9. Cheng LT, Tang W, Wang T. 2005. Strong association between volume status and nutritional status in peritoneal dialysis patients. Am J Kidney Dis, 45:891-902.
10. Cooper BA, Penne EL, Bartlett LH, et al. 2004. Protein malnutrition and hypoalbuminemia as predictors of vascular events and mortality in ESRD. Am J Kidney Dis, 43:61-6.
11. Cruickshank K, Riste L, Anderson SG, et al. 2002. Aortic pulse-wave velocity and its relationship to mortality in diabetes and glucose intolerance: An integrated index of vascular function? Circulation, 106:2085-90.
12. Danielski M, Ikizler TA, McMonagle E, et al. 2003. Linkage of hypoalbuminemia, inflammation, and oxidative stress in patients receiving maintenance hemodialysis therapy. Am J Kidney Dis, 42:286-94.
13. Dart AM, Kingwell BA. 2001. Pulse pressure - a review of mechanisms and clinical relevance. J Am Coll Cardiol, 37:975-84.
14. Djousse L, Rothman KJ, Cupples A., et al. 2003. Relation between serum albumin and carotid atherosclerosis The NHLBI Family Heart Study. Stroke, 34:53-7.
15. Dogra GK, Herrmann S, Irish AB, et al. 2002. Insulin resistance, dyslipidaemia, inflammation and endothelial function in nephrotic syndrome. Nephrol Dial Transplant, 17:2220-5.
16. Enia G, Mallamaci F, Benedetto FA, et al. 2001. Long-term CAPD patients are volume expanded and display more severe left ventricular hypertrophy than haemodialysis patients. Nephrol Dial Transplant, 16:1459-64.
17. Foley RN, Parfrey PS, Harnett JD, et al. 1995. Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int, 47:186-92.
18. Foley RN, Parfrey PS, Harriett JD, et al. 1996. Hypoalbuminemia, cardiac morbidity, and mortality in end-stage renal disease. J Am Soc Nephrol, 7:728-36.
19. Guerin A, Blacher J, Pannier B, et al. 2001. Impact of aortic stiffness attenuation on survival of patients in end-stage renal disease. Circulation, 103:987-92.
20. Hansen TW, Staessen JA, Torp-Pedersen C, et al. 2006. Prognostic value of aortic pulse wave velocity as index of arterial stiffness in the general population. Circulation, 113:664-70.
21. Jules JA, Stroes ES, Rabelink TJ. 1999. Endothelial function in proteinuric renal disease. Kidney Int Suppl, 71:S57-S61.
22. Joven J, Espinel E, Simo JM, et al. 1996. The influence of hypoalbuminemia in the generation of nephrotic hyperlipidemia. Atherosclerosis, 126:243-52.
23. Kalantar-Zadeh K, Kilpatrick RD, Kuwae N, et al. 2005. Revisiting mortality predictability of serum albumin in the dialysis population: time dependency, longitudinal changes and population-attributable fraction. Nephrol Dial Transplant, 20:1880-8.
24. Laurent S, Boutouyrie P, Asmar R, et al. 2001. Aortic stiffness is an independent risk predictor of all-cause and mortality in hypertensive patients. Hypertension, 37:1236-41.
25. Lip GY, Blann AD. 1995. Von Willebrand factor and its relevance to cardiovascular disorders. Br Heart J, 74:580-3.
26. O'Rourke MF, Staessen JA, Vlachojannis JA, et al. 2002. Clinical application of arterial stiffness:definitions and reference values. Am J Hypertens, 15:426-44.
27. Quinlan GJ, Mumby S, Martin GS, et al. 2004. Albumin influences total plasma antioxidant capacity favorably in patients with acute lung injury. Crit Care Med, 32:755-9.
28. Reuben DB, Ferrucci L, Wallace R, et al. 2000. The prognostic value of serum albumin in healthy older persons with low and high senim interleukin-6 (IL-6) Levels. J Am Geriatr Soc, 48:1404-7.
29. Scolnik D, Balfe JW. 1993. Initial hypoalbuminemia and hyperlipidemia persist during chronic peritoneal dialysis in children. Perit Dial Int, 13:136-9.
30. Shoji T, Nishizawa Y, Nishitani H, et al. 1991. Roles of hypoalbuminemia and lipoprotein lipase on hyperlipoproteinemia in continuous ambulatory peritoneal dialysis. Metabolism, 40:1002-8.
31. Van Bortel LM, Struijker-Boudier HA, Safar ME. 2001. Pulse pressure, arterial stiffness, and drug treatment of hypertension. Hypertension, 38:914-21.
32. Vlachopoulos C, O'Rourke M. 2000. Diastolic pressure, systolic pressure, or pulse pressure? Curr Hypertens Rep, 2:271-9.
33. Wong CS, Hingorani S, Gillen DL, et al. 2002. Hypoalbuminemia and risk of death in pediatric patients with end-stage renal disease. Kidney Int, 61:630-7.
34. Yang WS, Min WK, Park JS, et al. 1997. Effect of increasing serum albumin on serum lipoprotein(a) concentration in patients receiving CAPD. Am J Kidney Dis, 30:507-13.